Enfusion, Inc. Net Debt to Free Cash Flow
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|
| Net Debt to Free Cash Flow | 2.9x | (25.4x) | 7.7x | (8.3x) | (1.3x) | (1.1x) |
Enfusion, Inc. (ENFN) Net Debt to Free Cash Flow comparison analysis
General
LTM Net Debt to Free Cash Flow
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
ENFN key stats
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|
% growth | 59.0 0.0% | 79.6 34.8% | 111.7 40.4% | 150.3 34.6% | 174.5 16.1% | 201.6 15.5% |
| Cost of Goods Sold (COGS) | 17.0 | 21.4 | 31.8 | 47.1 | 57.6 | 64.9 |
% margin | 42.1 71.3% | 58.2 73.2% | 79.9 71.5% | 103.2 68.7% | 116.9 67.0% | 136.7 67.8% |
| Operating Expenses | 28.2 | 52.1 | 355.7 | 115.2 | 104.9 | 130.6 |
| Research & Development Expenses (R&D) | 4.1 | 6.3 | 153.4 | 17.2 | 19.9 | 26.7 |
| Selling, General & Administrative Expenses (SG&A) | 24.1 | 45.8 | 202.3 | 98.1 | 85.1 | 103.9 |
% margin | 13.9 23.5% | 6.1 7.6% | (275.9) (247.0%) | (12.0) (8.0%) | 11.9 6.8% | 6.2 3.1% |
| Interest Income | 0.7 | 1.7 | 4.6 | 0.4 | 0.0 | 1.7 |
| Interest Expense | 0.7 | 1.7 | 4.6 | 0.4 | 0.0 | 0.0 |
| Pre-tax Income | 13.1 | 4.5 | (281.7) | (12.2) | 11.5 | 7.4 |
% effective tax rate | 0.5 3.7% | 0.4 9.6% | 0.6 (0.2%) | 1.1 (8.8%) | 2.2 19.4% | 4.6 61.8% |
% margin | 12.7 21.4% | 4.1 5.1% | (282.2) (252.7%) | (13.3) (8.8%) | 6.0 3.5% | 2.8 1.4% |
| EPS | 0.11 | 0.04 | (4.30) | (0.16) | 0.10 | 0.02 |
| Diluted EPS | 0.11 | 0.04 | (4.30) | (0.16) | 0.07 | 0.01 |
% margin | 15.0 25.5% | 8.4 10.5% | (271.9) (243.4%) | (5.6) (3.7%) | 21.9 12.6% | 6.2 3.1% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Enfusion, Inc.'s Net Debt to Free Cash Flow?
As of today, Microsoft Corp's last 12-month Net Debt to Free Cash Flow is (1.4x), based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Net Debt to Free Cash Flow for Enfusion, Inc. have been (1.8x) over the past three years, and (2.6x) over the past five years.
2) Is Enfusion, Inc.'s Net Debt to Free Cash Flow Good?
As of today, Enfusion, Inc.'s Net Debt to Free Cash Flow is (1.4x), which is lower than industry median of (0.3x). It indicates that Enfusion, Inc.'s Net Debt to Free Cash Flow is Good.